Abstract
The susceptibility of 428 clinical isolates of Mycobacterium tuberculosis to pyrazinamide was assessed by the Bactec method and the Wayne pyrazinamidase assay. The correlation between the two tests was 98.2 and 100% for susceptible and resistant strains, respectively. False resistance was seen in four (0.8%) strains with the Bactec test, and false-susceptible results occurred in two (0.5%) pyrazinamidase assays. The Bactec test is rapid and reliable, and the Bactec results correlate well with the pyrazinamidase test results, although some strains did not grow well in the test medium.
Full Text
The Full Text of this article is available as a PDF (187.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Butler W. R., Kilburn J. O. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol. 1982 Dec;16(6):1106–1109. doi: 10.1128/jcm.16.6.1106-1109.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butler W. R., Kilburn J. O. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother. 1983 Oct;24(4):600–601. doi: 10.1128/aac.24.4.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- David H. L. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol. 1970 Nov;20(5):810–814. doi: 10.1128/am.20.5.810-814.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuursted K. Comparison of growth and susceptibility testing of pyrazinamide in different Bactec media using strains of the M. tuberculosis complex. APMIS. 1993 Feb;101(2):154–159. doi: 10.1111/j.1699-0463.1993.tb00095.x. [DOI] [PubMed] [Google Scholar]
- McClatchy J. K., Tsang A. Y., Cernich M. S. Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob Agents Chemother. 1981 Oct;20(4):556–557. doi: 10.1128/aac.20.4.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salfinger M., Heifets L. B. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob Agents Chemother. 1988 Jul;32(7):1002–1004. doi: 10.1128/aac.32.7.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salfinger M., Kafader F. M. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jul;265(3-4):404–407. [PubMed] [Google Scholar]
- Stottmeier K. D., Beam R. E., Kubica G. P. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Am Rev Respir Dis. 1967 Nov;96(5):1072–1075. doi: 10.1164/arrd.1967.96.5.1072. [DOI] [PubMed] [Google Scholar]
- Trivedi S. S., Desai S. G. Pyrazinamidase activity of Mycobacterium tuberculosis--a test of sensitivity to pyrazinamide. Tubercle. 1987 Sep;68(3):221–224. doi: 10.1016/0041-3879(87)90058-4. [DOI] [PubMed] [Google Scholar]
- Tummon R. Growth inhibition of mycobacterium tuberculosis by oleate in acidified medium. Med Lab Technol. 1975 Jul;32(3):229–232. [PubMed] [Google Scholar]
- Wayne L. G. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis. 1974 Jan;109(1):147–151. doi: 10.1164/arrd.1974.109.1.147. [DOI] [PubMed] [Google Scholar]